Evidence map›Paper›PMID 11466189›Full record

Trial reportArchives of disease in childhood2001

Persistent wheezing in infants with an atopic tendency responds to inhaled fluticasone.

R J Chavasse, Y Bastian-Lee, H Richter, T Hilliard, P Seddon

Open access · bronzeAbstract readClinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Archives of disease in childhood, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 74 citations in OpenAlex.

  1. Treatment of Severe Acute Asthma is Damage Control.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2013
    Article
  2. The management of pre-school wheeze.Paediatric respiratory reviews · 2011
    Review
  3. An approach to preschool wheezing: to label as asthma?The World Allergy Organization journal · 2010
    Article
  4. Wheeze in preschool children.BMJ (Clinical research ed.) · 2008
    Article
  5. How has research changed my practice in the last 5 years?Archives of disease in childhood · 2007
    Article
  6. Management of unresponsive asthma.Indian journal of pediatrics · 2004
    Review
  7. Research in general paediatrics.Archives of disease in childhood · 2004
    Article
  8. How do we treat wheezing infants? Evidence or anecdote.Archives of disease in childhood · 2002
    Article
  9. Diagnosing asthma in young children.Current allergy and asthma reports · 2002
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

R J ChavasseThe Royal Alexandra Hospital for Sick Children, Dyke Road, Brighton BN1 3JN, UK. chavasse@madasafish.com
Y Bastian-Lee
H Richter
T Hilliard
P Seddon
Royal Alexandra Children's Hospital · GBRoyal Alexandra Hospital · GBRoyal Brompton Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe role of inhaled corticosteroids for the treatment of wheeze in infancy remains unclear.

aimTo investigate the effect of inhaled fluticasone on symptoms in a group of wheezy infants who had a high risk of progressing to childhood asthma.

methodsA total of 52 infants, under 1 year of age, with a history of wheeze or cough and a history (personal or first degree relative) of atopy were prescribed either 150 microg fluticasone twice daily (group F) or placebo (group P), via metered dose inhaler, for 12 weeks following a two week run in period. Symptoms were scored in a parent held diary and the mean daily symptom score (MDS) and symptom free days (SFD) calculated for each two week period.

resultsThirty seven infants completed the study. Both MDS and SFD improved significantly between the run in and final two week period in group F, but not group P, with a mean difference in change (95% CI) between groups of 1.12 (0.05 to 2.18) for MDS and median difference of 3.0 (0.002 to 8.0) for SFD.

conclusionImprovement of clinical symptoms in response to fluticasone can be shown in this high risk group of infants. In the absence of effective alternatives inhaled corticosteroids should be considered in this patient group.

Indexed as

Administration, InhalationAirway ResistanceAndrostadienesAsthmaDouble-Blind MethodFemaleFluticasoneFunctional Residual CapacityGlucocorticoidsHumansImmunoglobulin EInfantLinear ModelsMaleRespiratory SoundsStatistics, NonparametricAndrostadienesFluticasoneGlucocorticoidsImmunoglobulin E

Identifiers

PMID11466189
PMCPMC1718878
OpenAlexW2109088853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.